ISSN 2147-9720 | E-ISSN 2148-4279
RELATED ARTICLES
Case Report
Methorexate therapy in a patient with rheumatoid arthritis complicated by idiopathic thrombocytopenic purpura
(Eur J Rheumatol 2015; 2: 39-40)
DOI: 10.5152/eurjrheumatol.2014.14065
Visceral Leishmaniasis in a patient with rheumatoid arthritis undergoing treatment with methotrexate: Case report and review of the literature
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2017.16066
Therapy resistant idiopathic scleredema: an underlying pathology not always present
(Eur J Rheumatol 2015; 2: 163-164)
DOI: 10.5152/eurjrheum.2015.0004
Spontaneous regression of Epstein-Barr virus-associated lymphoproliferative disorder in a juvenile idiopathic arthritis patient after the discontinuation of methotrexate and etanercept
(Eur J Rheumatol ; : -)
DOI: 10.5152/eurjrheum.2016.032
Refractory optic perineuritis due to granulomatosis with polyangiitis successfully treated with methotrexate and mycophenolate mofetil combination therapy
(Eur J Rheumatol 2017; 4: 70-72)
DOI: 10.5152/eurjrheum.2016.028
Original Article
Real-life experience of using conventional diseasemodifying anti-rheumatic drugs (DMARDs) in psoriatic arthritis (PsA). Retrospective analysis of the efficacy of methotrexate, sulfasalazine, and leflunomide in PsA...
(Eur J Rheumatol 2017; 4: 1-10)
DOI: 10.5152/eurjrheum.2017.1608
Serum calreticulin as a novel biomarker of juvenile idiopathic arthritis disease activity
(Eur J Rheumatol 2017; 4: 19-23)
DOI: 10.5152/eurjrheum.2017.160071
Key Words
Authors
All
Author’s Corner
Survey
AVES | Copyright © 2017 Medical Research and Education Association | Latest Update: 01.03.2017